NSABP Participating Sites
NSABP 参与地点
基本信息
- 批准号:7220608
- 负责人:
- 金额:$ 6.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-10 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:AftercareBiological MarkersBiologyBreastBreast Cancer Prevention TrialBreast Cancer Prognostic FactorCaringClinicClinicalClinical ServicesClinical TrialsCollaborationsComplementCounty HospitalsDisadvantagedDiseaseERBB2 geneGene AbnormalityGene Expression ProfileGeneral HospitalsGenomicsGoalsGrantHospitalsInvestigationMammary NeoplasmsMedicineMethodist ChurchMinorityNational Surgical Adjuvant Breast and Bowel ProjectNatureNeoadjuvant TherapyNumbersOutcomePatientsPilot ProjectsPopulationPrediction of Response to TherapyPrincipal InvestigatorPrognostic FactorPrognostic MarkerPublicationsRateRecruitment ActivityReproduction sporesResearchResearch InfrastructureResearch PersonnelScientistSiteSouthwest Oncology GroupTP53 geneTamoxifenTechnologyTimeTissuesTranslational ResearchTrastuzumabTumor BiologyValidationWomanWomen&aposs GroupWorkbasecDNA Arrayschemotherapycollegedensityexperiencehormone therapyimprovedmalignant breast neoplasmmembermultidisciplinaryoncologyresearch studyresponsetreatment trial
项目摘要
DESCRIPTION (provided by applicant): The Breast Care Center at Baylor College of Medicine is a broad based, multidisciplinary organization composed of investigators dedicated to exploring the biology of breast cancer, and through a better understanding of this biology, to improving cure rates and treatments for the disease. The strengths of the Center will complement, reinforce, and extend the goals of the NSABP. Over the past five years, we have established a clinical presence and infrastructure at Baylor College of Medicine which facilitates the recruitment of a wide variety of patients onto treatment studies. Along with our Breast Care Center, established in collaboration with The Methodist Hospital, we have also been successful in establishing a dedicated breast oncology clinic at Ben Taub General Hospital, a county hospital which serves a large number of disadvantaged and minority women with breast cancer, and are successfully recruiting from this population. Center investigators have developed a considerable expertise over the past twenty-five years in molecular markers of prognosis and prediction of response to therapy, and most recently have extended their efforts into high through-put genomic technologies. Through the combined strength of a busy, high volume clinical service and established clinical trial infrastructure, along with scientists and clinicians deeply experienced in translational and molecular marker research, we will be able to make a unique contribution towards the NSABP's goal of optimum, individualized treatment for all women with breast cancer.
描述(由申请人提供):贝勒医学院的乳房护理中心是一个基础广泛的多学科组织,由致力于探索乳腺癌生物学的研究人员组成,并通过更好地了解这种生物学,提高治愈率和疾病的治疗。该中心的优势将补充、加强和扩大国家生物安保战略的目标。在过去的五年中,我们已经在贝勒医学院建立了临床存在和基础设施,这有助于招募各种各样的患者进行治疗研究。沿着我们与卫理公会医院合作建立的乳房护理中心,我们还成功地在Ben Taub综合医院建立了一个专门的乳腺肿瘤诊所,该医院是一家县医院,为大量患有乳腺癌的弱势和少数民族妇女提供服务,并成功地从这一人群中招募人员。在过去的25年里,中心的研究人员在预后和治疗反应预测的分子标志物方面积累了相当丰富的专业知识,最近他们将努力扩展到高通量基因组技术。通过结合忙碌、大量的临床服务和已建立的临床试验基础设施,沿着在转化和分子标记物研究方面经验丰富的科学家和临床医生,我们将能够为NSABP为所有乳腺癌女性提供最佳、个性化治疗的目标做出独特的贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JENNY C-N CHANG其他文献
JENNY C-N CHANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JENNY C-N CHANG', 18)}}的其他基金
Dual targeting of PI3K and NOS pathways in Metaplastic BreastCancer (MBC)
化生性乳腺癌 (MBC) 中 PI3K 和 NOS 通路的双重靶向
- 批准号:
10739097 - 财政年份:2023
- 资助金额:
$ 6.65万 - 项目类别:
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
一项评估 PI3K/AKT 和 NOS 通路双重靶向治疗化生性乳腺癌 (MpBC) 的 II 期多中心试验
- 批准号:
10642669 - 财政年份:2022
- 资助金额:
$ 6.65万 - 项目类别:
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
一项评估 PI3K/AKT 和 NOS 通路双重靶向治疗化生性乳腺癌 (MpBC) 的 II 期多中心试验
- 批准号:
10393358 - 财政年份:2022
- 资助金额:
$ 6.65万 - 项目类别:
Targeting the Inflammasome As a Treatment Strategy for COVID-19 infected cancer patients
以炎症小体为目标作为治疗 COVID-19 感染癌症患者的策略
- 批准号:
10161460 - 财政年份:2016
- 资助金额:
$ 6.65万 - 项目类别:
Center for Immunotherapeutic Transport Oncophysics
免疫治疗运输肿瘤物理学中心
- 批准号:
9752959 - 财政年份:2016
- 资助金额:
$ 6.65万 - 项目类别:
Targeting Notch, PI3K-AKT and Other Novel Pathways in Breast Cancer Stem Cells
靶向乳腺癌干细胞中的 Notch、PI3K-AKT 和其他新途径
- 批准号:
8111136 - 财政年份:2008
- 资助金额:
$ 6.65万 - 项目类别:
Targeting Notch, PI3K-AKT and other novel pathways in breast cancer stem cells
靶向乳腺癌干细胞中的 Notch、PI3K-AKT 和其他新通路
- 批准号:
8255996 - 财政年份:2008
- 资助金额:
$ 6.65万 - 项目类别:
Targeting Notch, PI3K-AKT and other novel pathways in breast cancer stem cells
靶向乳腺癌干细胞中的 Notch、PI3K-AKT 和其他新通路
- 批准号:
7691767 - 财政年份:2008
- 资助金额:
$ 6.65万 - 项目类别:
Treatment Resistance Pathways & Targeting Residula Cancers
治疗耐药途径
- 批准号:
7385522 - 财政年份:2007
- 资助金额:
$ 6.65万 - 项目类别:
相似海外基金
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
- 批准号:
10490338 - 财政年份:2021
- 资助金额:
$ 6.65万 - 项目类别:
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
- 批准号:
10353104 - 财政年份:2021
- 资助金额:
$ 6.65万 - 项目类别:
Investigating pollution dynamics of swimming pool waters by means of chemical and biological markers
利用化学和生物标记物研究游泳池水体的污染动态
- 批准号:
21K04320 - 财政年份:2021
- 资助金额:
$ 6.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
- 批准号:
10688286 - 财政年份:2021
- 资助金额:
$ 6.65万 - 项目类别:
Novel biological markers for immunotherapy and comprehensive genetic analysis in thymic carcinoma
用于胸腺癌免疫治疗和综合遗传分析的新型生物标志物
- 批准号:
20K17755 - 财政年份:2020
- 资助金额:
$ 6.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
10578649 - 财政年份:2019
- 资助金额:
$ 6.65万 - 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
10295141 - 财政年份:2019
- 资助金额:
$ 6.65万 - 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
10041708 - 财政年份:2019
- 资助金额:
$ 6.65万 - 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
9776149 - 财政年份:2019
- 资助金额:
$ 6.65万 - 项目类别:
Combining biological and non-biological markers to develop a model predictive of treatment response for individuals with depression
结合生物和非生物标志物来开发预测抑郁症患者治疗反应的模型
- 批准号:
2063934 - 财政年份:2018
- 资助金额:
$ 6.65万 - 项目类别:
Studentship














{{item.name}}会员




